1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Glucose-6-Phosphate Isomerase (GPI)

Glucose-6-Phosphate Isomerase (GPI) 

Glucose-6-Phosphate Isomerase

Glucose-6-Phosphate Isomerase (GPI), the second enzyme in the glycolytic pathway, is a dimeric enzyme that catalyzes the conversion of glucose-6-phosphate to fructose-6-phosphate. Glucose-6-Phosphate Isomerase has been linked to the proliferation and motility of cancer cells via its control over glucose-6-phosphate levels. Aside from being a glycolytic intermediate, it has been seen that in certain cancers glucose-6-phosphate can act as a tumor secreted-cytokine as well as an angiogenesis-promoting factor. Moreover, Glucose-6-Phosphate Isomerase induces the expression of a matrix metalloproteinase-3 protein in some cancer cells, which subsequently increases tumor invasiveness[1].

Glucose-6-Phosphate Isomerase (GPI) 相关产品 (2):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-124890
    Thr101 Inhibitor 99.36%
    Thr101 是磷酸甘露糖异构酶 (PMI) 的抑制剂 (IC50=2.9 μM)。PMI 可与磷酸甘露糖变位酶 2 (PMM2) 竞争 Man-6-P 的结合位点,将 6- 磷酸甘露糖 (Man-6-P) 转化为 6-磷酸果糖 (Fru-6-P)。Thr101 只特异性抑制 PMI,不抑制 PMM2。Thr101 可用于糖基化 Ia 型先天性疾病 (CDG-Ia) 的研究。
    Thr101
  • HY-N6841
    Rhodiolin Inhibitor
    Rhodiolin 是一种类黄酮,是一种口服有效的葡萄糖6-磷酸异构酶 (GPI) 抑制剂。Rhodiolin 通过靶向糖酵解中葡萄糖-6-磷酸异构酶 GPI,抑制 PI3K/AKT/mTOR 磷酸化,从而抑制乳头状甲状腺癌 (PTC),并诱导细胞凋亡 (apoptosis)。Rhodiolin 可靶向 NS2B-NS3,从而抑制登革热病毒的复制。Rhodiolin 也是开发抑制 CK1ε 激酶的抗癌策略的潜在候选者。Rhodiolin 可用于抗肿瘤和抗病毒研究。
    Rhodiolin